Document Detail

Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.
MedLine Citation:
PMID:  11061249     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Intracerebral hemorrhage (ICH) is the most feared complication of warfarin therapy. The pathogenesis of this often-fatal complication remains obscure. Cerebral amyloid angiopathy (CAA) is a major cause of spontaneous lobar hemorrhage in the elderly and is associated with specific alleles of the APOE gene. OBJECTIVE: To assess the role of CAA in warfarin-associated ICH. METHODS: Clinical characteristics and APOE genotype were compared between 41 patients with warfarin-related ICH (from a cohort of 59 consecutive patients aged > or = 65 years with supratentorial ICH on warfarin) and 66 randomly selected individuals aged > or = 65 years without ICH taking warfarin. In addition, all neuropathologic specimens from ICH patients were reviewed for the presence and severity of CAA. RESULTS: Hemorrhages tended to be in the lobar regions of the brain, and most (76%) occurred with an international normalized ratio of < or = 3.0. The APOE epsilon2 allele was overrepresented among patients with warfarin-associated lobar hemorrhage (allele frequency 0.13 versus 0.04 in control subjects; p = 0.031). After controlling for other variables associated with ICH, carriers of the epsilon2 allele had an OR of 3.8 (95% CI, 1.0 to 14.6) for lobar ICH. CAA was pathologically diagnosed as the cause of lobar hemorrhage in 7 of 11 patients with available tissue samples. CONCLUSIONS: CAA is an important cause of warfarin-associated lobar ICH in the elderly. Although diagnosis of CAA before hemorrhage is not yet possible, these data offer hope that future patients at high risk for hemorrhage may be identified before initiation of warfarin therapy.
J Rosand; E M Hylek; H C O'Donnell; S M Greenberg
Related Documents :
25354579 - Variations of the perforin gene in patients with chronic inflammatory demyelinating pol...
25240429 - 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-p...
19812929 - Does idiopathic normal pressure hydrocephalus always mean a poor prognosis?
25450859 - Current approaches to the pharmacological management of cushing's disease.
25466359 - Evaluation of dysphagia at the initial diagnosis of amyotrophic lateral sclerosis.
25257389 - Overrepresentation of hla-dq2 in small intestinal neuroendocrine tumor patients.
14626629 - The relationship between serum ferritin levels and disease activity in systemic lupus e...
10627779 - Mood disorders in patients after treatment for primary intracranial tumours.
23583989 - Snoring is associated with an impaired motor function, disease severity and the quality...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neurology     Volume:  55     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-11-03     Completed Date:  2000-11-21     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  947-51     Citation Subset:  AIM; IM    
Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Apolipoproteins E / genetics
Cerebral Amyloid Angiopathy / genetics*,  pathology*
Cerebral Hemorrhage / complications,  genetics*,  pathology*
Prospective Studies
Warfarin / adverse effects*
Grant Support
Reg. No./Substance:
0/Apolipoproteins E; 81-81-2/Warfarin
Comment In:
Neurology. 2000 Oct 10;55(7):907-8   [PMID:  11061242 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study.
Next Document:  Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurologi...